Literature DB >> 20585715

A surgical tendonitis model in horses: technique, clinical, ultrasonographic and histological characterisation.

M Schramme1, S Hunter, N Campbell, A Blikslager, R Smith.   

Abstract

OBJECTIVE: Tendon injuries are common in all athletic activities in both humans and horses. Research of treatment modalities for this disease has typically been performed on a model of collagenase-induced tendonitis. This model has several disadvantages. Our hypothesis was that a reproducible core lesion could be created surgically in superficial digital flexor tendons (SDFT), which could then be evaluated consistently using ultrasonography.
MATERIALS AND METHODS: Four horses free of forelimb lameness were used in this study. Each horse underwent general anaesthesia and a synovial resector was used to create a core lesion in the SDFT of each forelimb. Sonographic examination was conducted weekly using 2 cm intervals between a section 7 and 25 cm distal to the accessory carpal bone. At two, four, eight, and 12 weeks after injury, a horse was euthanatized. Histopathological evaluation of the SDFT was performed at the same levels as the sonographic examination.
RESULTS: Only mild clinical signs of tendonitis were observed. Ultrasonographic core lesions were 10-16 cm long and had a mean maximum cross-sectional area (CSA) of 18.25 +/- 5.91% occurring at 17-23 cm distal to the accessory carpal bone, and a mean volume of 1.86 +/- 0.26 cm(3). Mean duration taken to achieve maximum lesion CSA and lesion volume was 35 +/- 7 days. Histologically, the lesions were characterised by mild inflammation followed by fibroplasia.
CONCLUSION: The reported surgical technique resulted in core lesions that were consistent in size and location, were readily evaluated with ultrasonography, and showed similarities with the ultrasonographic and histological progression of naturally occurring tendonitis lesions.

Entities:  

Mesh:

Year:  2010        PMID: 20585715     DOI: 10.3415/VCOT-09-10-0106

Source DB:  PubMed          Journal:  Vet Comp Orthop Traumatol        ISSN: 0932-0814            Impact factor:   1.358


  13 in total

1.  Efficacy of intra-tendinous injection of platelet-rich plasma in treating tendinosis: comprehensive assessment of a rat model.

Authors:  Benjamin Dallaudière; Marta Lempicki; Lionel Pesquer; Liliane Louedec; Pierre Marie Preux; Philippe Meyer; Vincent Hummel; Ahmed Larbi; Lydia Deschamps; Clement Journe; Agathe Hess; Alain Silvestre; Paul Sargos; Philippe Loriaut; Patrick Boyer; Elisabeth Schouman-Claeys; Jean Baptiste Michel; Jean Michel Serfaty
Journal:  Eur Radiol       Date:  2013-06-26       Impact factor: 5.315

2.  Using Short Term of High Power Laser Therapy in Horse's Tendon Injuries.

Authors:  S E Jaafar; A A H Al-Bayti; S I Abdullah
Journal:  Arch Razi Inst       Date:  2021-11-30

3.  Focal experimental injury leads to widespread gene expression and histologic changes in equine flexor tendons.

Authors:  Else Jacobson; Else Jacobsen; Andrew J Dart; Takamitsu Mondori; Neil Horadogoda; Leo B Jeffcott; Christopher B Little; Margaret M Smith
Journal:  PLoS One       Date:  2015-04-02       Impact factor: 3.240

4.  Effect of single intralesional treatment of surgically induced equine superficial digital flexor tendon core lesions with adipose-derived mesenchymal stromal cells: a controlled experimental trial.

Authors:  Florian Geburek; Florian Roggel; Hans T M van Schie; Andreas Beineke; Roberto Estrada; Kathrin Weber; Maren Hellige; Karl Rohn; Michael Jagodzinski; Bastian Welke; Christof Hurschler; Sabine Conrad; Thomas Skutella; Chris van de Lest; René van Weeren; Peter M Stadler
Journal:  Stem Cell Res Ther       Date:  2017-06-05       Impact factor: 6.832

5.  MRI-Based Assessment of Intralesional Delivery of Bone Marrow-Derived Mesenchymal Stem Cells in a Model of Equine Tendonitis.

Authors:  Alexandra Scharf; Shannon P Holmes; Merrilee Thoresen; Jennifer Mumaw; Alaina Stumpf; John Peroni
Journal:  Stem Cells Int       Date:  2016-09-26       Impact factor: 5.443

6.  Evaluation of Autologous Protein Solution Injection for Treatment of Superficial Digital Flexor Tendonitis in an Equine Model.

Authors:  Angela M Gaesser; Claire Underwood; Renata L Linardi; Kayla M Even; Virginia B Reef; Snehal S Shetye; Robert L Mauck; William J King; Julie B Engiles; Kyla F Ortved
Journal:  Front Vet Sci       Date:  2021-07-05

7.  Beneficial effects of autologous bone marrow-derived mesenchymal stem cells in naturally occurring tendinopathy.

Authors:  Roger Kenneth Whealands Smith; Natalie Jayne Werling; Stephanie Georgina Dakin; Rafiqul Alam; Allen E Goodship; Jayesh Dudhia
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

8.  Equine tendonitis therapy using mesenchymal stem cells and platelet concentrates: a randomized controlled trial.

Authors:  Armando de Mattos Carvalho; Peres Ramos Badial; Luis Emiliano Cisneros Álvarez; Ana Lucia Miluzzi Yamada; Alexandre Secorun Borges; Elenice Deffune; Carlos Alberto Hussni; Ana Liz Garcia Alves
Journal:  Stem Cell Res Ther       Date:  2013-07-22       Impact factor: 6.832

9.  Tracking of autologous adipose tissue-derived mesenchymal stromal cells with in vivo magnetic resonance imaging and histology after intralesional treatment of artificial equine tendon lesions--a pilot study.

Authors:  Florian Geburek; Kathrin Mundle; Sabine Conrad; Maren Hellige; Ulrich Walliser; Hans T M van Schie; René van Weeren; Thomas Skutella; Peter M Stadler
Journal:  Stem Cell Res Ther       Date:  2016-02-01       Impact factor: 6.832

10.  Longitudinal Cell Tracking and Simultaneous Monitoring of Tissue Regeneration after Cell Treatment of Natural Tendon Disease by Low-Field Magnetic Resonance Imaging.

Authors:  Dagmar Berner; Walter Brehm; Kerstin Gerlach; Claudia Gittel; Julia Offhaus; Felicitas Paebst; Doreen Scharner; Janina Burk
Journal:  Stem Cells Int       Date:  2016-01-10       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.